Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alon Liberman

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Diabetes Technology & Therapeutics|February 19, 2020
Diabetes Technologies and the Human FactorAlon Liberman, Katharine Barnard-Kelly
Diabetes Technology & Therapeutics|February 28, 2013
Diabetes technology and the human factorAlon Liberman, Bruce Buckingham, Moshe Phillip
Diabetes Technology & Therapeutics|February 1, 2014
Diabetes technology and the human factorAlon Liberman, Bruce Buckingham, Moshe Phillip
International Journal of Clinical Practice. Supplement|February 8, 2012
Diabetes technology and the human factorAlon Liberman, Bruce Buckingham, Moshe Phillip
Diabetes Technology & Therapeutics|February 14, 2015
Diabetes technology and the human factorAlon Liberman, Moshe Phillip, Bruce Buckingham
Physical Review Letters|April 23, 2021
SO(5) Non-Fermi Liquid in a Coulomb Box DeviceAndrew K Mitchell, Alon Liberman, Eran Sela, et al.
Pain Research & Management|December 21, 2011
Duloxetine contributing to a successful multimodal treatment program for peripheral femoral neuropathy and comorbid 'reactive depression' in an adolescentLudmyla Kachko, Shiri Ben Ami, Alon Liberman, et al.
Diabetes Technology & Therapeutics|December 3, 2019
Executive Functions and Adherence to Continuous Glucose Monitoring in Children and Adolescents with Type 1 DiabetesAlon Farfel, Alon Liberman, Michal Yackobovitch-Gavan, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|May 17, 2024
Nondisclosure of Type 1 Diabetes in Adolescence: A Single-Center ExperienceJudith Nir, Alon Liberman, Michal Yackobovitch-Gavan, et al.
Journal of Pediatric Psychology|September 3, 2025
Examination and expansion of the entire modified dual pathway model of disordered eating among individuals with type 1 diabetesTamar Propper-Lewinsohn, Shlomit Shalitin, Michal Gillon-Keren, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Diabetes Technology & Therapeutics|February 19, 2020
Diabetes Technologies and the Human FactorAlon Liberman, Katharine Barnard-Kelly
Diabetes Technology & Therapeutics|February 28, 2013
Diabetes technology and the human factorAlon Liberman, Bruce Buckingham, Moshe Phillip
Diabetes Technology & Therapeutics|February 1, 2014
Diabetes technology and the human factorAlon Liberman, Bruce Buckingham, Moshe Phillip
International Journal of Clinical Practice. Supplement|February 8, 2012
Diabetes technology and the human factorAlon Liberman, Bruce Buckingham, Moshe Phillip
Diabetes Technology & Therapeutics|February 14, 2015
Diabetes technology and the human factorAlon Liberman, Moshe Phillip, Bruce Buckingham
Physical Review Letters|April 23, 2021
SO(5) Non-Fermi Liquid in a Coulomb Box DeviceAndrew K Mitchell, Alon Liberman, Eran Sela, et al.
Pain Research & Management|December 21, 2011
Duloxetine contributing to a successful multimodal treatment program for peripheral femoral neuropathy and comorbid 'reactive depression' in an adolescentLudmyla Kachko, Shiri Ben Ami, Alon Liberman, et al.
Diabetes Technology & Therapeutics|December 3, 2019
Executive Functions and Adherence to Continuous Glucose Monitoring in Children and Adolescents with Type 1 DiabetesAlon Farfel, Alon Liberman, Michal Yackobovitch-Gavan, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|May 17, 2024
Nondisclosure of Type 1 Diabetes in Adolescence: A Single-Center ExperienceJudith Nir, Alon Liberman, Michal Yackobovitch-Gavan, et al.
Journal of Pediatric Psychology|September 3, 2025
Examination and expansion of the entire modified dual pathway model of disordered eating among individuals with type 1 diabetesTamar Propper-Lewinsohn, Shlomit Shalitin, Michal Gillon-Keren, et al.
Pageof 3